99-15475. Dietary Supplements; Center for Food Safety and Applied Nutrition; Public Meeting  

  • [Federal Register Volume 64, Number 117 (Friday, June 18, 1999)]
    [Proposed Rules]
    [Pages 32830-32831]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-15475]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 111
    
    [Docket No. 96N-0417]
    
    
    Dietary Supplements; Center for Food Safety and Applied 
    Nutrition; Public Meeting
    
    Agency: Food and Drug Administration, HHS.
    
    Action: Notice of public meeting.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
    meeting to solicit comments that will assist the Center for Food Safety 
    and Applied Nutrition (CFSAN) to understand the economic impact that 
    any proposal to establish current good manufacturing practices (CGMP's) 
    regulations for dietary supplements may have on small businesses in the 
    dietary supplement industry. This meeting is intended to give 
    interested persons, including small businesses, an opportunity to 
    comment on the economic impact that such a proposal may have on small 
    businesses.
    
    DATES: The public meeting will be held on Monday, July 12, 1999, from 7 
    p.m. to 9 p.m. You must register by July 7, 1999. You may submit 
    written comments until August 12, 1999.
    
    ADDRESSES: The public meeting will be held at the Flamingo Hotel, The 
    Carson City II Room, 3555 Las Vegas Blvd., Las Vegas, NV. Submit 
    written comments to the Dockets Management Branch (HFA-305), Docket No. 
    96N-0417, Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
    Rockville, MD 20852. Two copies of any comments are to be submitted, 
    except that individuals may submit one copy.
    
    FOR FURTHER INFORMATION CONTACT: Peter J. Vardon, Center for Food 
    Safety and Applied Nutrition (HFS-726), Food and Drug Administration, 
    330 C St. SW., Washington, DC 20204, 202-205-5329, FAX 202-260-0794, or 
    e-mail pvardon@bangate.fda.gov.
    
        If you would like to attend the public meeting, you should register 
    by July 7, 1999, by faxing or e-mailing your name, title, firm name, 
    address, and telephone number to Peter Vardon (address above).
        There is no registration fee for this public meeting, but early 
    registration is suggested because space may be limited.
    SUPPLEMENTARY INFORMATION: This public meeting will provide an 
    opportunity for an open discussion of the manufacturing practices of 
    small businesses in the dietary supplement industry. The meeting is 
    intended to be one of a series intended to give all interested parties 
    an opportunity to comment on the economic effects of a possible 
    proposed regulation on CGMP's in the dietary supplement industry. This 
    public meeting is also intended to fulfill part of the outreach 
    requirement of Small Business Regulatory Enforcement Fairness Act of 
    1996. The agenda will include topics regarding the small business 
    entities' manufacturing practices and standard operating procedures 
    for: (1) Personnel, (2) buildings and facilities, (3) equipment, (4) 
    lab operations, (5) production and process controls, and (6) 
    warehousing, distribution and post-distribution of raw, intermediate 
    and final products. The meeting will also include a discussion about 
    the verification of the identity, purity, and composition of dietary 
    supplements and dietary supplement ingredients.
    
    [[Page 32831]]
    
        FDA encourages individuals or firms with relevant data or 
    information to present such information at the meeting or in written 
    comments to the record.
        You may request a transcript of the public meeting from the Freedom 
    of Information Office (HFI-35), Food and Drug Administration, 5600 
    Fishers Lane, rm. 12A-16, Rockville, MD 20857, approximately 15 working 
    days after the meeting. The transcript of the public meeting and 
    submitted comments will be available for public examination at the 
    Dockets Management Branch (address above) between 9 a.m. and 4 p. m., 
    Monday through Friday.
    
        Dated: June 11, 1999.
    Margaret M. Dotzel,
    Acting Associate Commissioner for Policy Coordination.
    [FR Doc. 99-15475 Filed 6-17-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/18/1999
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notice of public meeting.
Document Number:
99-15475
Dates:
The public meeting will be held on Monday, July 12, 1999, from 7 p.m. to 9 p.m. You must register by July 7, 1999. You may submit written comments until August 12, 1999.
Pages:
32830-32831 (2 pages)
Docket Numbers:
Docket No. 96N-0417
PDF File:
99-15475.pdf
CFR: (1)
21 CFR 111